To demonstrate the therapeutic potential of L1 in Alzheimer’s disease, we used a mouse AD model with the accelerated progression of disease symptoms, which we used in our previous publications, a transgenic mouse APP/PS1 on a C57BL/6J inbred genetic background. The gene discussed is PSEN1; the disease is Alzheimer disease.